Equity Research, Broker Reports, and media content on AstraZeneca PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about AstraZeneca PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

AstraZeneca PLC

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on AstraZeneca PLC. We currently have 252 research reports from 11 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 6736/9081p
  • Daily Volume: N/A
  • Daily Liquidity: (0.08%)
  • # Shares: 1,549m
  • Market Cap: £139,577m
  • Latest PE (hist): 42.03
  • Div Yield: 2.36
Date Source Announcement
18Oct21 07:00 RNS AstraZeneca PLC - AZ recommends ADS holders reject mini-tender offer
15Oct21 07:00 RNS AstraZeneca PLC - Imfinzi & tremelimumab improved OS in liver cancer
11Oct21 07:00 RNS AstraZeneca PLC - AZD7442 PhIII trial positive in COVID outpatients
04Oct21 07:00 RNS AstraZeneca PLC - Enhertu granted BTD for breast cancer
01Oct21 15:00 RNS AstraZeneca PLC - Total Voting Rights
30Sep21 16:00 RNS AstraZeneca PLC - Director/PDMR Shareholding
29Sep21 07:00 RNS AstraZeneca PLC - AstraZeneca to fully acquire Caelum Biosciences
  • Frequency of research reports

     

  • Research reports on

    AstraZeneca PLC

  • Providers covering

    AstraZeneca PLC